Katie Beal, MD - Medicare Obstetrics & Gynecology in Bentonville, AR

Katie Beal, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Bentonville, Arkansas. Her current practice location is 2900 Medical Center Pkwy Ste 240a, Bentonville, Arkansas. You can reach out to her office (for appointments etc.) via phone at (479) 553-3340.

Katie Beal is licensed to practice in Arkansas (license number E-10369) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1558709469.

Contact Information

Katie Beal, MD
2900 Medical Center Pkwy Ste 240a,
Bentonville, AR 72712-3204
(479) 553-3340
(479) 553-1964



Physician's Profile

Full NameKatie Beal
GenderFemale
SpecialityObstetrics & Gynecology
Location2900 Medical Center Pkwy Ste 240a, Bentonville, Arkansas
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1558709469
  • Provider Enumeration Date: 06/13/2013
  • Last Update Date: 09/08/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 3375777220
  • Enrollment ID: I20170711000527

Medical Identifiers

Medical identifiers for Katie Beal such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1558709469NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207V00000XObstetrics & Gynecology 2013017461 (Missouri)Secondary
207V00000XObstetrics & Gynecology E-10369 (Arkansas)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Katie Beal allows following entities to bill medicare on her behalf.
Entity NameNorthwest Benton County Physician Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1871553073
PECOS PAC ID: 3577503689
Enrollment ID: O20050509000505

News Archive

D614G mutation in SARS-CoV-2 increases viral fitness and infectivity

Researchers from the Duke Human Vaccine Institute and Duke University, Durham NC, USA, recently analyzed the D614G mutation in SARS-CoV-2 in the context of a soluble S ectodomain construct. Their study has been published in the preprint server bioRxiv.

Jennerex presents positive preliminary data from JX-594 Phase 2 trial for advanced liver cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the design, development and commercialization of first-in-class targeted oncolytic products for cancer, today presented preliminary data from a randomized dose-ranging Phase 2 trial of JX-594 in patients with advanced liver cancer showing a benefit in overall survival for the high dose group.

New study presents promising results for treatment of multiple myeloma

A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School, USA, and Karolinska Institutet, Sweden, presents very promising results for the treatment of the cancer form multiple myeloma. The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university. The findings are so promising that the scientists are teaming up with Harvard to bring the drug to clinical trials on patients.

LA dentist offers special service packages for Christmas season

To celebrate Christmas and the holiday season, Los Angeles dentist Dr. Neda Naim is thanking new patients for scheduling appointments by providing specials on selected services throughout December.

CHMP recommends conditional marketing authorisation for Janssen's daratumumab

Janssen-Cilag announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the granting of a conditional marketing authorisation for first-in-class CD38 immunotherapy daratumumab in the European Union.

Read more Medical News

› Verified 6 days ago

Entity NameLifespring Women's Healthcare Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1164519450
PECOS PAC ID: 1254332083
Enrollment ID: O20070123000090

News Archive

D614G mutation in SARS-CoV-2 increases viral fitness and infectivity

Researchers from the Duke Human Vaccine Institute and Duke University, Durham NC, USA, recently analyzed the D614G mutation in SARS-CoV-2 in the context of a soluble S ectodomain construct. Their study has been published in the preprint server bioRxiv.

Jennerex presents positive preliminary data from JX-594 Phase 2 trial for advanced liver cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the design, development and commercialization of first-in-class targeted oncolytic products for cancer, today presented preliminary data from a randomized dose-ranging Phase 2 trial of JX-594 in patients with advanced liver cancer showing a benefit in overall survival for the high dose group.

New study presents promising results for treatment of multiple myeloma

A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School, USA, and Karolinska Institutet, Sweden, presents very promising results for the treatment of the cancer form multiple myeloma. The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university. The findings are so promising that the scientists are teaming up with Harvard to bring the drug to clinical trials on patients.

LA dentist offers special service packages for Christmas season

To celebrate Christmas and the holiday season, Los Angeles dentist Dr. Neda Naim is thanking new patients for scheduling appointments by providing specials on selected services throughout December.

CHMP recommends conditional marketing authorisation for Janssen's daratumumab

Janssen-Cilag announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the granting of a conditional marketing authorisation for first-in-class CD38 immunotherapy daratumumab in the European Union.

Read more Medical News

› Verified 6 days ago

Entity NameArkansas Health Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1598031882
PECOS PAC ID: 7911802079
Enrollment ID: O20120611000172

News Archive

D614G mutation in SARS-CoV-2 increases viral fitness and infectivity

Researchers from the Duke Human Vaccine Institute and Duke University, Durham NC, USA, recently analyzed the D614G mutation in SARS-CoV-2 in the context of a soluble S ectodomain construct. Their study has been published in the preprint server bioRxiv.

Jennerex presents positive preliminary data from JX-594 Phase 2 trial for advanced liver cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the design, development and commercialization of first-in-class targeted oncolytic products for cancer, today presented preliminary data from a randomized dose-ranging Phase 2 trial of JX-594 in patients with advanced liver cancer showing a benefit in overall survival for the high dose group.

New study presents promising results for treatment of multiple myeloma

A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School, USA, and Karolinska Institutet, Sweden, presents very promising results for the treatment of the cancer form multiple myeloma. The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university. The findings are so promising that the scientists are teaming up with Harvard to bring the drug to clinical trials on patients.

LA dentist offers special service packages for Christmas season

To celebrate Christmas and the holiday season, Los Angeles dentist Dr. Neda Naim is thanking new patients for scheduling appointments by providing specials on selected services throughout December.

CHMP recommends conditional marketing authorisation for Janssen's daratumumab

Janssen-Cilag announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the granting of a conditional marketing authorisation for first-in-class CD38 immunotherapy daratumumab in the European Union.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Katie Beal is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Katie Beal, MD
500 N Keene St, Suite 400,
Columbia, MO 65201-8104

Ph: () -
Katie Beal, MD
2900 Medical Center Pkwy Ste 240a,
Bentonville, AR 72712-3204

Ph: (479) 553-3340

News Archive

D614G mutation in SARS-CoV-2 increases viral fitness and infectivity

Researchers from the Duke Human Vaccine Institute and Duke University, Durham NC, USA, recently analyzed the D614G mutation in SARS-CoV-2 in the context of a soluble S ectodomain construct. Their study has been published in the preprint server bioRxiv.

Jennerex presents positive preliminary data from JX-594 Phase 2 trial for advanced liver cancer

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the design, development and commercialization of first-in-class targeted oncolytic products for cancer, today presented preliminary data from a randomized dose-ranging Phase 2 trial of JX-594 in patients with advanced liver cancer showing a benefit in overall survival for the high dose group.

New study presents promising results for treatment of multiple myeloma

A new study conducted by scientists from the Dana-Farber Cancer Institute at Harvard Medical School, USA, and Karolinska Institutet, Sweden, presents very promising results for the treatment of the cancer form multiple myeloma. The drug candidate used in the research has been developed by scientists from Karolinska Institutet and a Swedish company following its initial identification at the same university. The findings are so promising that the scientists are teaming up with Harvard to bring the drug to clinical trials on patients.

LA dentist offers special service packages for Christmas season

To celebrate Christmas and the holiday season, Los Angeles dentist Dr. Neda Naim is thanking new patients for scheduling appointments by providing specials on selected services throughout December.

CHMP recommends conditional marketing authorisation for Janssen's daratumumab

Janssen-Cilag announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended the granting of a conditional marketing authorisation for first-in-class CD38 immunotherapy daratumumab in the European Union.

Read more News

› Verified 6 days ago


Obstetrics & Gynecology Doctors in Bentonville, AR

Audra Cole, D.O.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1200 Se 28th St Ste 2, Bentonville, AR 72712
Phone: 479-271-0005    Fax: 479-273-1427
Dr. Lawrence Schmitz, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1200 Se 28th St, Ste. 2, Bentonville, AR 72712
Phone: 479-271-0005    Fax: 479-273-1427
Dr. James Todd Hannah, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 1200 Se 28th St, Ste 2, Bentonville, AR 72712
Phone: 479-271-0005    Fax: 479-273-1427
Dr. Lisa Ann Bearden, MD
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 2900 Medical Center Pkwy, Suite 370, Bentonville, AR 72712
Phone: 479-876-8111    Fax: 479-876-8110
Amber June Sills, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 2900 Medical Center Pkwy, Suite 370, Bentonville, AR 72712
Phone: 479-553-2525    
Dr. Amy M Fry, M.D.
Obstetrics & Gynecology
Medicare: Accepting Medicare Assignments
Practice Location: 2900 Medical Center Pkwy Ste 240a, Bentonville, AR 72712
Phone: 795-533-3340    Fax: 479-553-1964

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.